EUVIMEDEUVIMED entdecken
Crossref

Initial Triple Combination Therapy Including Intravenous Prostaglandin I2 for the Treatment of Patients with Severe Pulmonary Arterial Hypertension

Yuichi Tamura, Hiraku Kumamaru, Shiori Nishimura, Yasuo Nakajima, Hiromi Matsubara, Yu Taniguchi, Ichizo Tsujino, Ayako Shigeta, Koichiro Kinugawa, Kazuhiro Kimura, Koichiro Tatsumi

International Heart Journal · 2023

DOI: 10.1536/ihj.23-047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Heart Journal, 2023. Verfasst von Yuichi Tamura und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary Hypertension Center, International University of Health and Welfare Mita Hospital. Hauptthemen laut MEDLINE: Epoprostenol, Pulmonary Arterial Hypertension, Antihypertensive Agents, Hypertension, Pulmonary. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpoprostenolPulmonary Arterial HypertensionAntihypertensive AgentsHypertension, PulmonaryHumansMaleFemaleMiddle AgedRetrospective StudiesDrug Therapy, CombinationAdultJapanRegistriesTreatment OutcomeSeverity of Illness IndexAged

Stichwörter der Autor:innen

Endothelin receptor antagonistPhosphodiesterase-5 inhibitorProstacyclin analogPulmonary arterial pressureRegistryRight-sided heart failure

Substanzen

EpoprostenolAntihypertensive Agents

Autor:innen und Institutionen

  • Pulmonary Hypertension Center, International University of Health and Welfare Mita Hospital.
  • Japan Pulmonary Hypertension Registry (JAPHR) Network.
  • Department of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo.
  • Medical Division, GSK K.K.
  • National Hospital Organization Okayama Medical Center.
  • Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine.

Zitieren

APA

Tamura, Y., Kumamaru, H., Nishimura, S., Nakajima, Y., Matsubara, H., Taniguchi, Y., Tsujino, I., Shigeta, A., Kinugawa, K., Kimura, K., & Tatsumi, K. (2023). Initial Triple Combination Therapy Including Intravenous Prostaglandin I2 for the Treatment of Patients with Severe Pulmonary Arterial Hypertension. International Heart Journal. https://doi.org/10.1536/ihj.23-047

Vancouver

Tamura Y, Kumamaru H, Nishimura S, Nakajima Y, Matsubara H, Taniguchi Y, et al. Initial Triple Combination Therapy Including Intravenous Prostaglandin I2 for the Treatment of Patients with Severe Pulmonary Arterial Hypertension. International Heart Journal. 2023. doi:10.1536/ihj.23-047

BibTeX
@article{Tamura2023,
  author = {Tamura, Yuichi and Kumamaru, Hiraku and Nishimura, Shiori and Nakajima, Yasuo and Matsubara, Hiromi and Taniguchi, Yu and Tsujino, Ichizo and Shigeta, Ayako and Kinugawa, Koichiro and Kimura, Kazuhiro and Tatsumi, Koichiro},
  title = {Initial Triple Combination Therapy Including Intravenous Prostaglandin I2 for the Treatment of Patients with Severe Pulmonary Arterial Hypertension},
  journal = {International Heart Journal},
  year = {2023},
  doi = {10.1536/ihj.23-047}
}
Kostenlos starten →